Clinical Dermatology - part 3 pot
Clinical Dermatology - part 3 pot
... 200 g/week of a mildly potent steroid, 50 g/week of a moderately potent or 30 g/week of a potent one for long periods. Very potent topical steroids should not be used long-term. Treatment Acute ... in a non-allergic manner (e.g. aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin-converting enzyme (ACE) inhibitors and morphine). Contact urticaria This may be IgE-mediated .....
Ngày tải lên: 14/08/2014, 07:20
Chapter 064. The Practice of Genetics in Clinical Medicine (Part 3) potx
... Figure 6 4-1 A 36 -year-old woman (arrow) seeks consultation because of her family history of cancer. Chapter 064. The Practice of Genetics in Clinical Medicine (Part 3) Recall ... aforementioned features of the family history are illustrated in Fig. 6 4-1 . In this example, the proband, a 36 -year-old woman (IV-1), has a strong history of breast and ovarian canc...
Ngày tải lên: 07/07/2014, 01:20
Chapter 067. Applications of Stem Cell Biology in Clinical Medicine (Part 3) pot
... of Stem Cell Biology in Clinical Medicine (Part 3) Diabetes Mellitus The success of islet cell and pancreas transplantation provides proof of concept for a cell-based approach for type ... treatment for end-stage liver diseases, but this approach is limited by the shortage of liver grafts. Clinical trials of hepatocyte transplantation demonstrate that it can potentially substi...
Ngày tải lên: 07/07/2014, 01:20
Evidence based Dermatology - part 3 pot
... pustulosis palmo-plantaris and eczema keratoticum manuum. Dermatologica 1982; 164 :209–16. 33 . Bollag W, Ott F. Successful treatment of chronic hand eczema with oral 9- cis -retinoic acid. Dermatology 1999; 199 :30 8–12. 34 . ... al . 1998 (USA) 6 Twice-daily tacrolimus ointment 0· 03% , 0·1% and 0 3% v vehicle alone (emollients and bath oils only) Twice-daily tacrolimus ointment 0...
Ngày tải lên: 09/08/2014, 14:22
DIABETIC NEUROPATHY: CLINICAL MANAGEMENT - PART 3 potx
... caspase-9 to Apaf-1 results in caspase-9-dependent hier- archical activation of caspases-2, -3 , -6 , -7 , -8 , and -1 0, resulting ultimately in DNA frag- mentation seen in apoptosis (50– 53) . In ... (50– 53) . In turn, caspase -3 activates caspase-2, -6 , -8 , and -1 0 and amplifies caspase-9 cleavage (50). In contrast, BCL-2 and BCL-xL complex with Apaf-1 and caspa...
Ngày tải lên: 10/08/2014, 18:21
Endocrinology Basic and Clinical Principles - part 3 pot
... IGF-1-dependent and -independent manner). The potential importance of the IGF system, and particularly the IGF-1R, in cancer has led to an intense effort to find blockers of IGF-1R function as potential adjuncts ... keratinocyte growth fac- tor. FGFs bind to low-affinity, high-capacity cell-sur- face proteoglycans containing heparan sulfate side chains as well as to high-affinity receptors wi...
Ngày tải lên: 10/08/2014, 18:21
BASIC AND CLINICAL DERMATOLOGY - PART 3 pps
... they oper- ate as physiological bypasses activated when needed. AVA represents the venous-return-system response to emergencies. However, if the emergency persists and becomes chronic, short-circuited ... derive in part from recent studies in microangiology, personal clinical observations, and response to a treat- ment protocol applied to over 500 patients between October 1, 1995, and Dec...
Ngày tải lên: 11/08/2014, 06:21
BASIC AND CLINICAL DERMATOLOGY - PART 7 potx
... Asociacion Medica Argentina, Diciembre 30 , 1 934 . 3. Romeuf JB. Etude sur l’injection sous cutanee de gaz thermaux de Royat. Clermont Ferrand. Imp Moderne, 15 rue du Port 31 , Mars 1940. 4. Gaillard A. ... blood flow. J Invest Dermatol 1989; 93: 259. 13. Brandi C, D’Aniello C, Grimaldi L, et al. Carbon dioxide therapy in the treatment of localized adip- osities: clinical study and his...
Ngày tải lên: 11/08/2014, 06:21
BASIC AND CLINICAL DERMATOLOGY - PART 10 pot
... 54 Lambert-Beer law, 81 Lanuois-Bensaudes syndrome, 57 L-carnitine, 166 Leukoanthocyanins, 1 43 Lidocaine, as anesthetic for Lipodissolve 1 , 31 1 Lipedema, 30 31 , 51, 59, 69 definition of, 30 evening, ... 174–176 Lipodissolve 1 , 30 1 30 9 active ingredients of, 30 1 contraindications for, 30 7 deoxycholate and, 30 5 dosages and techniques for, 30 9 fat pad dissolution, 31 0 gener...
Ngày tải lên: 11/08/2014, 06:21
Clinical Dermatology - part 5 pot
... biopsy will help sort out the non-dysplastic causes, such as lichen Fig. 13. 30 The curved slow-growing greenish-yellow nails of the yellow nail syndrome. CD3C 13 21/5/05 12:05 PM Page 179 158 CHAPTER ... 1000 days Sheds about 100 hairs/day Fig. 13. 3 An average scalp. CD3C 13 21/5/05 12:04 PM Page 1 63 162 Melanocytes migrate into the matrix and are respons- ible for the different colours...
Ngày tải lên: 14/08/2014, 07:20